ADCTADC Therapeutics SAvs its industry peers
A metric-by-metric comparison of ADC Therapeutics SA against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
Full peer comparison
Peers: same SEC industry (Pharmaceutical Preparations)| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADCTThis | $161M#8 | — | — | 2.0x#1 | 14.9%#4 | 9.6%#3 | -149.3%#3 | — | — | — | -61.7%#10 | — |
| AAPG | $7.0B#4 | — | — | — | — | — | — | — | — | — | -54.6%#7 | — |
| AARD | $125M#9 | — | 1.4x#1 | — | — | -179.7%#7 | — | -66.2%#5 | — | — | -55.6%#8 | — |
| ABBV | $435.3B#1 | 121.4x#4 | — | 7.1x#3 | 8.6%#5 | -1.2%#4 | 24.6%#1 | — | 20.0%#1 | — | 29.8%#4 | — |
| ABCL | $2.1B#5 | — | 2.2x#2 | 27.8x#4 | 160.6%#1 | 10.1%#2 | -289.0%#5 | -15.6%#3 | -25.2%#3 | — | 61.1%#2 | — |
| ABEO | $392M#7 | 7.2x#2 | 2.7x#3 | 67.3x#6 | — | -211.7%#8 | -1536.9%#6 | -49.1%#4 | -101.1%#5 | — | 17.3%#5 | — |
| ABT | $163.5B#2 | 26.3x#3 | 3.1x#4 | 3.7x#2 | 5.7%#6 | -51.3%#5 | 18.2%#2 | 12.5%#1 | 8.3%#2 | — | -28.0%#6 | 2.5%#1 |
| ABUS | $940M#6 | 5.7x#1 | 3.6x#5 | 66.8x#5 | 128.2%#2 | 52.1%#1 | -271.0%#4 | -12.9%#2 | — | — | 45.6%#3 | — |
| ABVC | $39M#10 | — | 3.6x#6 | 132.2x#7 | 48.0%#3 | -61.3%#6 | -2416.0%#7 | -73.4%#6 | -65.9%#4 | — | -55.6%#9 | — |
| ABVX | $11.0B#3 | — | — | — | — | — | — | — | — | — | 1600.8%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice